Literature DB >> 15475969

Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.

Karl-Magnus Larsson1, Albert Jordan, Rolf Eliasson, Peter Reichard, Derek T Logan, Pär Nordlund.   

Abstract

Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides into deoxyribonucleotides, which constitute the precursor pools used for DNA synthesis and repair. Imbalances in these pools increase mutational rates and are detrimental to the cell. Balanced precursor pools are maintained primarily through the regulation of the RNR substrate specificity. Here, the molecular mechanism of the allosteric substrate specificity regulation is revealed through the structures of a dimeric coenzyme B12-dependent RNR from Thermotoga maritima, both in complexes with four effector-substrate nucleotide pairs and in three complexes with only effector. The mechanism is based on the flexibility of loop 2, a key structural element, which forms a bridge between the specificity effector and substrate nucleotides. Substrate specificity is achieved as different effectors and their cognate substrates stabilize specific discrete loop 2 conformations. The mechanism of substrate specificity regulation is probably general for most class I and class II RNRs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475969     DOI: 10.1038/nsmb838

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  50 in total

1.  Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators.

Authors:  Md Faiz Ahmad; Sarah E Huff; John Pink; Intekhab Alam; Andrew Zhang; Kay Perry; Michael E Harris; Tessianna Misko; Suheel K Porwal; Nancy L Oleinick; Masaru Miyagi; Rajesh Viswanathan; Chris Godfrey Dealwis
Journal:  J Med Chem       Date:  2015-12-09       Impact factor: 7.446

2.  Determination of the in vivo stoichiometry of tyrosyl radical per betabeta' in Saccharomyces cerevisiae ribonucleotide reductase.

Authors:  Allison D Ortigosa; Daniela Hristova; Deborah L Perlstein; Zhen Zhang; Mingxia Huang; JoAnne Stubbe
Journal:  Biochemistry       Date:  2006-10-10       Impact factor: 3.162

3.  Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule.

Authors:  Md Faiz Ahmad; Intekhab Alam; Sarah E Huff; John Pink; Sheryl A Flanagan; Donna Shewach; Tessianna A Misko; Nancy L Oleinick; William E Harte; Rajesh Viswanathan; Michael E Harris; Chris Godfrey Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

4.  Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages.

Authors:  Baek Kim; Laura A Nguyen; Waaqo Daddacha; Joseph A Hollenbaugh
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

5.  Closing the circle on ribonucleotide reductases.

Authors:  Derek T Logan
Journal:  Nat Struct Mol Biol       Date:  2011-03       Impact factor: 15.369

6.  Phylogenetic sequence analysis and functional studies reveal compensatory amino acid substitutions in loop 2 of human ribonucleotide reductase.

Authors:  Andrew J Knappenberger; Sneha Grandhi; Reena Sheth; Md Faiz Ahmad; Rajesh Viswanathan; Michael E Harris
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

7.  Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: adenosylcobalamin destruction and formation of a nucleotide-based radical.

Authors:  Gregory J S Lohman; Gary J Gerfen; Joanne Stubbe
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

8.  Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation.

Authors:  Hai Xu; Catherine Faber; Tomoaki Uchiki; James W Fairman; Joseph Racca; Chris Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

9.  Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly.

Authors:  Hai Xu; Catherine Faber; Tomoaki Uchiki; Joseph Racca; Chris Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

10.  Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint.

Authors:  Dinesh Kumar; Jörgen Viberg; Anna Karin Nilsson; Andrei Chabes
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.